Expression of Thomsen–Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability

• Main Authors: Beatriz Leão, Xiaogang Wen, Henrique O. Duarte, Irene Gullo, Gilza Gonçalves, Patrícia Pontes, Claudia Castelli, Francisca Diniz, Stefan Mereiter, Joana Gomes, Fátima Carneiro, Celso A. Reis
• Format: Article
• Language: English
• Published: MDPI AG 2021-01-01
• Series: International Journal of Molecular Sciences
• Subjects: glycosylation; colorectal cancer; microsatellite instability; Thomsen–Friedenreich antigen; <i>O</i>-glycan
• Online Access: https://www.mdpi.com/1422-0067/22/3/1340
• ISSN: 1661-6596; 1422-0067

Microsatellite instability (MSI) is a molecular phenotype due to a deficient DNA mismatch repair (dMMR). In colorectal cancer (CRC), dMMR/MSI is associated with several clinical and histopathological features, influences prognosis, and is a predictive factor of response to therapy. In daily practice, dMMR/MSI profiles are identified by immunohistochemistry and/or multiplex PCR. The Thomsen–Friedenreich (TF) antigen was previously found to be a potential single marker to identify MSI-high gastric cancers. Therefore, in this study, we aimed to disclose a possible association between TF expression and MSI status in CRC. Furthermore, we evaluated the relationship between TF expression and other clinicopathological features, including patient survival. We evaluated the expression of the TF antigen in a cohort of 25 MSI-high and 71 microsatellite stable (MSS) CRCs. No association was observed between the expression of the TF antigen and MSI-high status in CRC. The survival analysis revealed that patients with MSI-high CRC showed improved survival when the TF antigen was expressed. This finding holds promise as it indicates the potential use of the TF antigen as a biomarker of better prognosis in MSI-high CRCs that should be validated in an independent and larger CRC cohort.